H.R.1885 - International Prescription Drug Parity Act106th Congress (1999-2000)
|Sponsor:||Rep. Berry, Marion [D-AR-1] (Introduced 05/20/1999)|
|Committees:||House - Commerce|
|Latest Action:||04/12/2000 Sponsor introductory remarks on measure. (CR H2186-2187) (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.1885 — 106th Congress (1999-2000)All Information (Except Text)
Introduced in House (05/20/1999)
International Prescription Drug Parity Act - Amends the Federal Food, Drug, and Cosmetic Act to require manufacturers of certain drugs manufactured and domestically approved and then exported, or domestically approved and manufactured in a registered foreign establishment, to: (1) maintain specified shipment compliance and labeling records; and (2) make such records available to U.S. importers.
Directs the Secretary of Health and Human Services to establish related criteria to facilitate the U.S. importation of such drugs.